The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Iguchi Kimi since 2014.
This trader's CIK number is 1304815.
At the time of last reporting, Iguchi Kimi was the CFO & Treasurer of Sage Therapeutics, Inc.. (stock ticker symbol SAGE).
Also see all insider trading activities at Sage Therapeutics, Inc..
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2023 | SAGE | 0 | $0 | 0 | $0 | 2,600 | $3,536 |
2022 | SAGE | 0 | $0 | 0 | $0 | 4,500 | $6,120 |
2021 | SAGE | 0 | $0 | 0 | $0 | 11,750 | $15,980 |
2020 | SAGE | 0 | $0 | 0 | $0 | 4,000 | $5,440 |
2019 | SAGE | 0 | $0 | 0 | $0 | 26,223 | $31,365 |
2018 | SAGE | 0 | $0 | 28,153 | $4,051,962 | 800 | $360 |
2017 | SAGE | 0 | $0 | 10,000 | $539,200 | 0 | $0 |
2016 | SAGE | 176 | $8,722 | 13,000 | $633,040 | 4,000 | $1,800 |
2015 | SAGE | 0 | $0 | 13,500 | $904,810 | 0 | $0 |
2014 | SAGE | 6,000 | $108,000 | 0 | $0 | 0 | $0 |
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2023-02-23 | SAGE | Option Ex | 250 | 1.36 | 340 |
2023-02-21 | SAGE | Option Ex | 750 | 1.36 | 1,020 |
2023-01-09 | SAGE | Option Ex | 1,600 | 1.36 | 2,176 |
2022-02-17 | SAGE | Option Ex | 4,500 | 1.36 | 6,120 |
2021-11-22 | SAGE | Option Ex | 2,500 | 1.36 | 3,400 |
2021-11-23 | SAGE | Option Ex | 1,000 | 1.36 | 1,360 |
2021-06-16 | SAGE | Option Ex | 2,000 | 1.36 | 2,720 |
2021-06-15 | SAGE | Option Ex | 3,000 | 1.36 | 4,080 |
2021-04-13 | SAGE | Option Ex | 1,500 | 1.36 | 2,040 |
2021-01-05 | SAGE | Option Ex | 1,750 | 1.36 | 2,380 |
2020-04-30 | SAGE | Option Ex | 4,000 | 1.36 | 5,440 |
2019-12-09 | SAGE | Option Ex | 15,000 | 1.36 | 20,400 |
2019-12-10 | SAGE | Option Ex | 500 | 1.36 | 680 |
2019-07-25 | SAGE | Option Ex | 2,000 | 1.36 | 2,720 |
2019-07-17 | SAGE | Option Ex | 4,000 | 1.36 | 5,440 |
2019-03-08 | SAGE | Option Ex | 4,723 | .45 | 2,125 |
2018-06-19 | SAGE | Option Ex | 800 | .45 | 360 |
2018-04-23 | SAGE | Sale | 12,135 | 146.21 | 1,774,234 |
2018-04-24 | SAGE | Sale | 5,000 | 143.86 | 719,310 |
2018-04-25 | SAGE | Sale | 11,018 | 141.44 | 1,558,418 |
2017-01-13 | SAGE | Sale | 10,000 | 53.92 | 539,200 |
2016-11-17 | SAGE | Sale | 4,000 | 51.77 | 207,080 |
2016-11-11 | SAGE | Sale | 1,500 | 50.59 | 75,885 |
2016-09-07 | SAGE | Sale | 2,500 | 40.93 | 102,325 |
2016-07-12 | SAGE | Sale | 5,000 | 49.55 | 247,750 |
2015-12-31 | SAGE | Buy | 176 | 49.56 | 8,722 |
2016-01-07 | SAGE | Option Ex | 4,000 | .45 | 1,800 |
2015-09-08 | SAGE | Sale | 3,000 | 54.84 | 164,520 |
2015-08-10 | SAGE | Sale | 4,000 | 67.01 | 268,040 |
2015-07-06 | SAGE | Sale | 4,000 | 68.00 | 272,000 |
2015-06-08 | SAGE | Sale | 2,500 | 80.10 | 200,250 |
2014-07-23 | SAGE | Buy | 6,000 | 18.00 | 108,000 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Iguchi Kimi (CFO & Treasurer of Sage Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.